1	Tat	_	NN	_	_	2	VMOD	_	_
2	activates	_	VBZ	_	_	10	VMOD	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	p65-dependent	_	JJ	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	NF-kappaB-responsive	_	JJ	_	_	8	NMOD	_	_
8	genes	_	NNS	_	_	6	PMOD	_	_
9	,	_	,	_	_	10	P	_	_
10	occupies	_	VBZ	_	_	0	ROOT	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	NF-kappaB	_	NN	_	_	13	NMOD	_	_
13	enhancers	_	NNS	_	_	10	VMOD	_	_
14	and	_	CC	_	_	10	COORD	_	_
15	promotes	_	VBZ	_	_	14	CONJ	_	_
16	the	_	DT	_	_	18	NMOD	_	_
17	p65	_	NN	_	_	18	NMOD	_	_
18	recruitment	_	NN	_	_	15	VMOD	_	_
19	with	_	IN	_	_	18	NMOD	_	_
20	IkappaB-alpha	_	NN	_	_	21	NMOD	_	_
21	displacement	_	NN	_	_	19	PMOD	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	analysed	_	VBD	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	action	_	NN	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	Tat	_	NN	_	_	5	PMOD	_	_
7	on	_	IN	_	_	4	NMOD	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	7	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	NF-kappaB-responsive	_	JJ	_	_	12	NMOD	_	_
12	genes	_	NNS	_	_	10	PMOD	_	_
13	in	_	FW	_	_	14	AMOD	_	_
14	vivo	_	FW	_	_	12	APPO	_	_
15	.	_	.	_	_	2	P	_	_
		
1	To	_	TO	_	_	7	VMOD	_	_
2	this	_	DT	_	_	3	NMOD	_	_
3	end	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	7	P	_	_
5	HeLa	_	NN	_	_	6	NMOD	_	_
6	cells	_	NNS	_	_	7	VMOD	_	_
7	were	_	VBD	_	_	0	ROOT	_	_
8	transfected	_	VBN	_	_	7	VC	_	_
9	with	_	IN	_	_	8	VMOD	_	_
10	FLAG-Tat	_	NN	_	_	9	PMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	FLAG-Tat	_	NN	_	_	13	NMOD	_	_
13	C(22,25,27)A	_	NN	_	_	10	COORD	_	_
14	or	_	CC	_	_	13	COORD	_	_
15	FLAG-Tat	_	NN	_	_	16	NMOD	_	_
16	R(49-57)A	_	NN	_	_	14	CONJ	_	_
17	,	_	,	_	_	7	P	_	_
18	and	_	CC	_	_	7	COORD	_	_
19	48	_	CD	_	_	20	NMOD	_	_
20	h	_	NN	_	_	21	AMOD	_	_
21	later	_	RB	_	_	30	VMOD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	expression	_	NN	_	_	30	VMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	a	_	DT	_	_	26	NMOD	_	_
26	number	_	NN	_	_	24	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	NF-kappaB-dependent	_	JJ	_	_	29	NMOD	_	_
29	genes	_	NNS	_	_	27	PMOD	_	_
30	was	_	VBD	_	_	18	CONJ	_	_
31	analysed	_	VBN	_	_	30	VC	_	_
32	by	_	IN	_	_	31	VMOD	_	_
33	real-time	_	JJ	_	_	34	NMOD	_	_
34	PCR	_	NN	_	_	32	PMOD	_	_
35	.	_	.	_	_	7	P	_	_
		
1	Tat	_	NN	_	_	3	VMOD	_	_
2	significantly	_	RB	_	_	3	VMOD	_	_
3	increased	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	MIP-1alpha	_	NN	_	_	6	PMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	CSF3	_	NN	_	_	7	COORD	_	_
10	,	_	,	_	_	9	P	_	_
11	LTA	_	NN	_	_	9	COORD	_	_
12	,	_	,	_	_	11	P	_	_
13	NFKBIA	_	NN	_	_	11	COORD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	TLR2	_	NN	_	_	14	CONJ	_	_
16	,	_	,	_	_	3	P	_	_
17	while	_	IN	_	_	3	VMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	mutants	_	NNS	_	_	25	VMOD	_	_
20	Tat	_	NN	_	_	21	NMOD	_	_
21	C(22,25,27)A	_	NN	_	_	19	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	Tat	_	NN	_	_	24	NMOD	_	_
24	R(49-57)A	_	NN	_	_	22	CONJ	_	_
25	were	_	VBD	_	_	17	SUB	_	_
26	ineffective	_	JJ	_	_	25	VMOD	_	_
27	(	_	(	_	_	29	P	_	_
28	Figure	_	NN	_	_	29	NMOD	_	_
29	5A-E	_	NN	_	_	26	PRN	_	_
30	)	_	)	_	_	29	P	_	_
31	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	Tat-dependent	_	JJ	_	_	3	NMOD	_	_
3	transactivation	_	NN	_	_	8	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	NF-kappaB-dependent	_	JJ	_	_	7	NMOD	_	_
7	genes	_	NNS	_	_	4	PMOD	_	_
8	was	_	VBD	_	_	0	ROOT	_	_
9	abolished	_	VBN	_	_	8	VC	_	_
10	when	_	WRB	_	_	12	VMOD	_	_
11	cells	_	NNS	_	_	12	VMOD	_	_
12	were	_	VBD	_	_	9	VMOD	_	_
13	transfected	_	VBN	_	_	12	VC	_	_
14	with	_	IN	_	_	13	VMOD	_	_
15	siRNA	_	NN	_	_	16	NMOD	_	_
16	p65	_	NN	_	_	14	PMOD	_	_
17	,	_	,	_	_	9	P	_	_
18	indicating	_	VBG	_	_	9	VMOD	_	_
19	that	_	IN	_	_	18	VMOD	_	_
20	the	_	DT	_	_	23	NMOD	_	_
21	Tat	_	NN	_	_	23	NMOD	_	_
22	transcriptional	_	JJ	_	_	23	NMOD	_	_
23	activation	_	NN	_	_	24	VMOD	_	_
24	was	_	VBD	_	_	19	SUB	_	_
25	mediated	_	VBN	_	_	24	VC	_	_
26	by	_	IN	_	_	25	VMOD	_	_
27	p65	_	NN	_	_	26	PMOD	_	_
28	(	_	(	_	_	30	P	_	_
29	Figure	_	NN	_	_	30	NMOD	_	_
30	5A-E	_	NN	_	_	27	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	.	_	.	_	_	8	P	_	_
		
1	Differently	_	RB	_	_	12	VMOD	_	_
2	,	_	,	_	_	12	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	12	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	NF-kappaB-independent	_	NN	_	_	8	NMOD	_	_
8	genes	_	NNS	_	_	5	PMOD	_	_
9	GAPDH	_	NN	_	_	8	APPO	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	ACTB	_	NN	_	_	10	CONJ	_	_
12	was	_	VBD	_	_	0	ROOT	_	_
13	unaffected	_	VBN	_	_	12	VC	_	_
14	by	_	IN	_	_	13	VMOD	_	_
15	wild-type	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	Tat	_	NN	_	_	18	NMOD	_	_
18	mutants	_	NNS	_	_	16	CONJ	_	_
19	(	_	(	_	_	20	P	_	_
20	Figure	_	NN	_	_	18	PRN	_	_
21	5F	_	NN	_	_	20	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	G	_	NN	_	_	22	CONJ	_	_
24	)	_	)	_	_	20	P	_	_
25	.	_	.	_	_	12	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	consistent	_	JJ	_	_	3	VMOD	_	_
5	with	_	IN	_	_	4	AMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	requirement	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	both	_	CC	_	_	14	DEP	_	_
10	the	_	DT	_	_	14	NMOD	_	_
11	cysteine-rich	_	JJ	_	_	14	NMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	arginine-rich	_	JJ	_	_	12	CONJ	_	_
14	domains	_	NNS	_	_	8	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	Tat	_	NN	_	_	15	PMOD	_	_
17	to	_	TO	_	_	7	NMOD	_	_
18	enhance	_	VB	_	_	17	IM	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	NF-kappaB	_	NN	_	_	21	NMOD	_	_
21	activity	_	NN	_	_	18	VMOD	_	_
22	,	_	,	_	_	3	P	_	_
23	suggesting	_	VBG	_	_	3	VC	_	_
24	that	_	IN	_	_	23	VMOD	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	up-regulation	_	NN	_	_	32	VMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	NF-kappaB-responsive	_	JJ	_	_	29	NMOD	_	_
29	genes	_	NNS	_	_	27	PMOD	_	_
30	by	_	IN	_	_	26	NMOD	_	_
31	Tat	_	NN	_	_	30	PMOD	_	_
32	might	_	MD	_	_	24	SUB	_	_
33	occur	_	VB	_	_	32	VC	_	_
34	through	_	IN	_	_	33	VMOD	_	_
35	physical	_	JJ	_	_	36	NMOD	_	_
36	interaction	_	NN	_	_	34	PMOD	_	_
37	of	_	IN	_	_	36	NMOD	_	_
38	the	_	DT	_	_	40	NMOD	_	_
39	viral	_	JJ	_	_	40	NMOD	_	_
40	protein	_	NN	_	_	37	PMOD	_	_
41	with	_	IN	_	_	36	NMOD	_	_
42	p65	_	NN	_	_	41	PMOD	_	_
43	and	_	CC	_	_	42	COORD	_	_
44	IkappaB-alpha	_	NN	_	_	43	CONJ	_	_
45	.	_	.	_	_	3	P	_	_
		
1	MIP-1alpha	_	NN	_	_	12	VMOD	_	_
2	,	_	,	_	_	1	P	_	_
3	which	_	WDT	_	_	4	VMOD	_	_
4	was	_	VBD	_	_	1	NMOD	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	mostly	_	RB	_	_	7	AMOD	_	_
7	activated	_	VBN	_	_	8	NMOD	_	_
8	gene	_	NN	_	_	4	VMOD	_	_
9	by	_	IN	_	_	4	VMOD	_	_
10	Tat	_	NN	_	_	9	PMOD	_	_
11	,	_	,	_	_	1	P	_	_
12	encodes	_	VBZ	_	_	0	ROOT	_	_
13	for	_	IN	_	_	12	VMOD	_	_
14	a	_	DT	_	_	15	NMOD	_	_
15	chemokine	_	NN	_	_	13	PMOD	_	_
16	that	_	WDT	_	_	17	VMOD	_	_
17	promotes	_	VBZ	_	_	15	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	recruitment	_	NN	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	pro-inflammatory	_	JJ	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	20	PMOD	_	_
23	(	_	(	_	_	24	P	_	_
24	56	_	CD	_	_	17	PRN	_	_
25	)	_	)	_	_	24	P	_	_
26	.	_	.	_	_	12	P	_	_
		
1	Consistently	_	RB	_	_	2	PMOD	_	_
2	with	_	IN	_	_	8	VMOD	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	findings	_	NNS	_	_	2	PMOD	_	_
5	,	_	,	_	_	8	P	_	_
6	MIP-1alpha	_	NN	_	_	7	NMOD	_	_
7	expression	_	NN	_	_	8	VMOD	_	_
8	was	_	VBD	_	_	0	ROOT	_	_
9	increased	_	VBN	_	_	8	VC	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	glial	_	JJ	_	_	12	NMOD	_	_
12	cells	_	NNS	_	_	10	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	lymph	_	NN	_	_	15	NMOD	_	_
15	nodes	_	NNS	_	_	13	CONJ	_	_
16	of	_	IN	_	_	12	NMOD	_	_
17	AIDS	_	NN	_	_	18	NMOD	_	_
18	patients	_	NNS	_	_	16	PMOD	_	_
19	(	_	(	_	_	20	P	_	_
20	57,58	_	NN	_	_	18	PRN	_	_
21	)	_	)	_	_	20	P	_	_
22	;	_	:	_	_	8	P	_	_
23	moreover	_	RB	_	_	27	VMOD	_	_
24	,	_	,	_	_	27	P	_	_
25	MIP-1alpha	_	NN	_	_	26	NMOD	_	_
26	production	_	NN	_	_	27	VMOD	_	_
27	was	_	VBD	_	_	8	COORD	_	_
28	induced	_	VBN	_	_	27	VC	_	_
29	by	_	IN	_	_	28	VMOD	_	_
30	HIV-1	_	NN	_	_	31	NMOD	_	_
31	infection	_	NN	_	_	29	PMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	59,60	_	NN	_	_	31	PRN	_	_
34	)	_	)	_	_	33	P	_	_
35	and	_	CC	_	_	31	COORD	_	_
36	Tat	_	NN	_	_	37	NMOD	_	_
37	protein	_	NN	_	_	35	CONJ	_	_
38	(	_	(	_	_	39	P	_	_
39	57,61,62	_	NN	_	_	37	PRN	_	_
40	)	_	)	_	_	39	P	_	_
41	.	_	.	_	_	8	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	transcriptional	_	JJ	_	_	3	NMOD	_	_
3	regulation	_	NN	_	_	6	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	MIP-1alpha	_	NN	_	_	4	PMOD	_	_
6	has	_	VBZ	_	_	0	ROOT	_	_
7	been	_	VBN	_	_	6	VC	_	_
8	poorly	_	RB	_	_	7	VMOD	_	_
9	characterized	_	VBN	_	_	7	VC	_	_
10	.	_	.	_	_	6	P	_	_
		
1	Jaspar-based	_	JJ	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	6	VMOD	_	_
3	(	_	(	_	_	4	P	_	_
4	http://jaspar.genereg.net/	_	NN	_	_	2	PRN	_	_
5	)	_	)	_	_	4	P	_	_
6	predicted	_	VBD	_	_	0	ROOT	_	_
7	three	_	CD	_	_	10	NMOD	_	_
8	putative	_	JJ	_	_	10	NMOD	_	_
9	NF-kappaB	_	NN	_	_	10	NMOD	_	_
10	enhancers	_	NNS	_	_	6	VMOD	_	_
11	in	_	IN	_	_	6	VMOD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	proximal	_	JJ	_	_	15	NMOD	_	_
14	promoter	_	NN	_	_	15	NMOD	_	_
15	region	_	NN	_	_	11	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	19	NMOD	_	_
18	MIP-1alpha	_	NN	_	_	19	NMOD	_	_
19	gene	_	NN	_	_	16	PMOD	_	_
20	:	_	:	_	_	21	P	_	_
21	NF-kappaB1	_	NN	_	_	6	PRN	_	_
22	,	_	,	_	_	21	P	_	_
23	-1023/-1014	_	CD	_	_	24	NMOD	_	_
24	nucleotides	_	NNS	_	_	21	COORD	_	_
25	;	_	:	_	_	24	P	_	_
26	NF-kappaB2	_	NN	_	_	24	COORD	_	_
27	,	_	,	_	_	26	P	_	_
28	-661/-652	_	CD	_	_	29	NMOD	_	_
29	nucleotides	_	NNS	_	_	26	COORD	_	_
30	;	_	:	_	_	29	P	_	_
31	NF-kappaB3	_	NN	_	_	29	COORD	_	_
32	,	_	,	_	_	31	P	_	_
33	+370/+379	_	CD	_	_	34	NMOD	_	_
34	nucleotides	_	NNS	_	_	31	COORD	_	_
35	(	_	(	_	_	38	P	_	_
36	Supplementary	_	NN	_	_	38	NMOD	_	_
37	Figure	_	NN	_	_	38	NMOD	_	_
38	S3A	_	NN	_	_	34	PRN	_	_
39	)	_	)	_	_	38	P	_	_
40	.	_	.	_	_	6	P	_	_
		
1	To	_	TO	_	_	14	VMOD	_	_
2	validate	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	7	NMOD	_	_
4	predicted	_	VBN	_	_	7	NMOD	_	_
5	NF-kappaB	_	NN	_	_	7	NMOD	_	_
6	binding	_	NN	_	_	7	NMOD	_	_
7	sites	_	NNS	_	_	2	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	MIP-1alpha	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	8	PMOD	_	_
12	,	_	,	_	_	14	P	_	_
13	we	_	PRP	_	_	14	VMOD	_	_
14	stimulated	_	VBD	_	_	0	ROOT	_	_
15	HeLa	_	NN	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	14	VMOD	_	_
17	with	_	IN	_	_	14	VMOD	_	_
18	TNF-alpha	_	NN	_	_	17	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	a	_	DT	_	_	23	NMOD	_	_
21	well-known	_	JJ	_	_	23	NMOD	_	_
22	NF-kappaB	_	NN	_	_	23	NMOD	_	_
23	inducer	_	NN	_	_	18	APPO	_	_
24	,	_	,	_	_	18	P	_	_
25	and	_	CC	_	_	14	COORD	_	_
26	measured	_	VBD	_	_	25	CONJ	_	_
27	the	_	DT	_	_	29	NMOD	_	_
28	expression	_	NN	_	_	29	NMOD	_	_
29	levels	_	NNS	_	_	26	VMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	MIP-1alpha	_	NN	_	_	30	PMOD	_	_
32	by	_	IN	_	_	29	NMOD	_	_
33	real-time	_	JJ	_	_	34	NMOD	_	_
34	PCR	_	NN	_	_	32	PMOD	_	_
35	,	_	,	_	_	29	P	_	_
36	and	_	CC	_	_	29	COORD	_	_
37	the	_	DT	_	_	39	NMOD	_	_
38	p65	_	NN	_	_	39	NMOD	_	_
39	occupancy	_	NN	_	_	36	CONJ	_	_
40	of	_	IN	_	_	39	NMOD	_	_
41	the	_	DT	_	_	43	NMOD	_	_
42	NF-kappaB	_	NN	_	_	43	NMOD	_	_
43	sites	_	NNS	_	_	40	PMOD	_	_
44	by	_	IN	_	_	39	NMOD	_	_
45	ChIP	_	NN	_	_	44	PMOD	_	_
46	.	_	.	_	_	14	P	_	_
		
1	TNF-alpha	_	NN	_	_	2	VMOD	_	_
2	activated	_	VBD	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	MIP-1alpha	_	NN	_	_	5	PMOD	_	_
7	and	_	CC	_	_	2	COORD	_	_
8	induced	_	VBD	_	_	7	CONJ	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	p65	_	NN	_	_	11	NMOD	_	_
11	recruitment	_	NN	_	_	8	VMOD	_	_
12	to	_	TO	_	_	11	NMOD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	NF-kappaB1	_	NN	_	_	15	NMOD	_	_
15	site	_	NN	_	_	12	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	MIP-1alpha	_	NN	_	_	16	PMOD	_	_
18	without	_	IN	_	_	8	VMOD	_	_
19	affecting	_	VBG	_	_	18	PMOD	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	occupancy	_	NN	_	_	19	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	28	NMOD	_	_
24	putative	_	JJ	_	_	28	NMOD	_	_
25	NF-kappaB2	_	NN	_	_	28	NMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	NF-kappaB3	_	NN	_	_	26	CONJ	_	_
28	sites	_	NNS	_	_	22	PMOD	_	_
29	(	_	(	_	_	32	P	_	_
30	Supplementary	_	JJ	_	_	32	NMOD	_	_
31	Figure	_	NN	_	_	32	NMOD	_	_
32	S3B	_	NN	_	_	28	PRN	_	_
33	and	_	CC	_	_	32	COORD	_	_
34	S3C	_	NN	_	_	33	CONJ	_	_
35	)	_	)	_	_	32	P	_	_
36	.	_	.	_	_	2	P	_	_
		
1	Tat	_	NN	_	_	3	VMOD	_	_
2	also	_	RB	_	_	3	VMOD	_	_
3	promoted	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	recruitment	_	NN	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	p65	_	NN	_	_	6	PMOD	_	_
8	to	_	TO	_	_	5	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	NF-kappaB1	_	NN	_	_	11	NMOD	_	_
11	site	_	NN	_	_	8	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	MIP-1alpha	_	NN	_	_	12	PMOD	_	_
14	,	_	,	_	_	3	P	_	_
15	while	_	IN	_	_	3	VMOD	_	_
16	it	_	PRP	_	_	17	VMOD	_	_
17	did	_	VBD	_	_	15	SUB	_	_
18	not	_	RB	_	_	17	VMOD	_	_
19	affect	_	VB	_	_	17	VC	_	_
20	the	_	DT	_	_	25	NMOD	_	_
21	putative	_	JJ	_	_	25	NMOD	_	_
22	NF-kappaB2	_	NN	_	_	25	NMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	NF-kappaB3	_	NN	_	_	23	CONJ	_	_
25	sites	_	NNS	_	_	19	VMOD	_	_
26	(	_	(	_	_	29	P	_	_
27	Supplementary	_	NN	_	_	29	NMOD	_	_
28	Figure	_	NN	_	_	29	NMOD	_	_
29	S3D	_	NN	_	_	25	PRN	_	_
30	)	_	)	_	_	29	P	_	_
31	.	_	.	_	_	3	P	_	_
		
1	Altogether	_	RB	_	_	4	VMOD	_	_
2	these	_	DT	_	_	3	NMOD	_	_
3	results	_	NNS	_	_	4	VMOD	_	_
4	indicated	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	NF-kappaB1	_	NN	_	_	8	NMOD	_	_
8	site	_	NN	_	_	9	VMOD	_	_
9	was	_	VBD	_	_	5	SUB	_	_
10	the	_	DT	_	_	14	NMOD	_	_
11	only	_	RB	_	_	12	AMOD	_	_
12	effective	_	JJ	_	_	14	NMOD	_	_
13	NF-kappaB	_	NN	_	_	14	NMOD	_	_
14	enhancer	_	NN	_	_	9	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	the	_	DT	_	_	18	NMOD	_	_
17	MIP-1alpha	_	NN	_	_	18	NMOD	_	_
18	promoter	_	NN	_	_	15	PMOD	_	_
19	in	_	IN	_	_	9	VMOD	_	_
20	response	_	NN	_	_	19	DEP	_	_
21	to	_	TO	_	_	19	DEP	_	_
22	TNF-alpha	_	NN	_	_	19	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	Tat	_	NN	_	_	23	CONJ	_	_
25	.	_	.	_	_	4	P	_	_
		
1	Similarly	_	RB	_	_	6	VMOD	_	_
2	to	_	TO	_	_	1	AMOD	_	_
3	MIP-1alpha	_	NN	_	_	2	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	Tat	_	NN	_	_	6	VMOD	_	_
6	increased	_	VBD	_	_	0	ROOT	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	recruitment	_	NN	_	_	6	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	p65	_	NN	_	_	9	PMOD	_	_
11	to	_	TO	_	_	8	NMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	NF-kappaB	_	NN	_	_	14	NMOD	_	_
14	enhancers	_	NNS	_	_	11	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	CSF3	_	NN	_	_	15	PMOD	_	_
17	,	_	,	_	_	16	P	_	_
18	LTA	_	NN	_	_	16	COORD	_	_
19	,	_	,	_	_	18	P	_	_
20	NFKBIA	_	NN	_	_	18	COORD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	TLR2	_	NN	_	_	21	CONJ	_	_
23	,	_	,	_	_	6	P	_	_
24	while	_	IN	_	_	6	VMOD	_	_
25	it	_	PRP	_	_	26	VMOD	_	_
26	was	_	VBD	_	_	24	SUB	_	_
27	ineffective	_	JJ	_	_	26	VMOD	_	_
28	at	_	IN	_	_	26	VMOD	_	_
29	the	_	DT	_	_	30	NMOD	_	_
30	promoters	_	NNS	_	_	28	PMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	GAPDH	_	NN	_	_	31	PMOD	_	_
33	and	_	CC	_	_	32	COORD	_	_
34	ACTB	_	NN	_	_	33	CONJ	_	_
35	(	_	(	_	_	37	P	_	_
36	Figure	_	NN	_	_	37	NMOD	_	_
37	5H	_	NN	_	_	34	PRN	_	_
38	)	_	)	_	_	37	P	_	_
39	.	_	.	_	_	6	P	_	_
		
1	By	_	IN	_	_	5	VMOD	_	_
2	ChIP	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	Tat	_	NN	_	_	5	VMOD	_	_
5	bound	_	VBD	_	_	0	ROOT	_	_
6	to	_	TO	_	_	5	VMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	NF-kappaB-responsive	_	JJ	_	_	9	NMOD	_	_
9	promoters	_	NNS	_	_	6	PMOD	_	_
10	,	_	,	_	_	6	P	_	_
11	and	_	CC	_	_	6	COORD	_	_
12	not	_	RB	_	_	13	DEP	_	_
13	to	_	TO	_	_	11	CONJ	_	_
14	the	_	DT	_	_	18	NMOD	_	_
15	GAPDH	_	NN	_	_	18	NMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	ACTB	_	NN	_	_	16	CONJ	_	_
18	promoters	_	NNS	_	_	13	PMOD	_	_
19	,	_	,	_	_	5	P	_	_
20	with	_	IN	_	_	5	VMOD	_	_
21	loss	_	NN	_	_	20	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	binding	_	VBG	_	_	22	PMOD	_	_
24	following	_	JJ	_	_	27	NMOD	_	_
25	p65	_	NN	_	_	27	NMOD	_	_
26	RNA	_	NN	_	_	27	NMOD	_	_
27	interference	_	NN	_	_	23	VMOD	_	_
28	(	_	(	_	_	30	P	_	_
29	Figure	_	NN	_	_	30	NMOD	_	_
30	5I	_	NN	_	_	27	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	,	_	,	_	_	5	P	_	_
33	suggesting	_	VBG	_	_	5	VMOD	_	_
34	that	_	IN	_	_	33	VMOD	_	_
35	Tat	_	NN	_	_	36	NMOD	_	_
36	occupancy	_	NN	_	_	37	VMOD	_	_
37	occurred	_	VBD	_	_	34	SUB	_	_
38	via	_	IN	_	_	37	VMOD	_	_
39	p65	_	NN	_	_	40	NMOD	_	_
40	interaction	_	NN	_	_	38	PMOD	_	_
41	.	_	.	_	_	5	P	_	_
		
1	As	_	IN	_	_	6	VMOD	_	_
2	additional	_	JJ	_	_	3	NMOD	_	_
3	findings	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	IkappaB-alpha	_	NN	_	_	6	VMOD	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	chromatin-immunoprecipitated	_	VBN	_	_	6	VC	_	_
8	at	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	NF-kappaB	_	NN	_	_	11	NMOD	_	_
11	enhancers	_	NNS	_	_	8	PMOD	_	_
12	in	_	IN	_	_	7	VMOD	_	_
13	absence	_	NN	_	_	12	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	Tat	_	NN	_	_	14	PMOD	_	_
16	,	_	,	_	_	6	P	_	_
17	and	_	CC	_	_	6	COORD	_	_
18	it	_	PRP	_	_	19	VMOD	_	_
19	was	_	VBD	_	_	17	CONJ	_	_
20	significantly	_	RB	_	_	19	VMOD	_	_
21	removed	_	VBN	_	_	19	VC	_	_
22	in	_	IN	_	_	21	VMOD	_	_
23	presence	_	NN	_	_	22	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	Tat	_	NN	_	_	24	PMOD	_	_
26	,	_	,	_	_	22	P	_	_
27	or	_	CC	_	_	22	COORD	_	_
28	following	_	VBG	_	_	27	CONJ	_	_
29	IkappaB-alpha	_	NN	_	_	31	NMOD	_	_
30	RNA	_	NN	_	_	31	NMOD	_	_
31	interference	_	NN	_	_	28	PMOD	_	_
32	(	_	(	_	_	34	P	_	_
33	Figure	_	NN	_	_	34	NMOD	_	_
34	5J	_	NN	_	_	31	PRN	_	_
35	)	_	)	_	_	34	P	_	_
36	,	_	,	_	_	19	P	_	_
37	indicating	_	VBG	_	_	19	VC	_	_
38	that	_	IN	_	_	37	VMOD	_	_
39	Tat	_	NN	_	_	40	VMOD	_	_
40	displaced	_	VBD	_	_	38	SUB	_	_
41	IkappaB-alpha	_	NN	_	_	40	VMOD	_	_
42	from	_	IN	_	_	40	VMOD	_	_
43	promoters	_	NNS	_	_	42	PMOD	_	_
44	.	_	.	_	_	6	P	_	_
		
